Oil prices rise on talk of Russia sanctions; bouncing off recent lows
LONDON - Haleon PLC (LSE/NYSE:HLN), a global leader in consumer health, announced the appointment of Matt Shattock as an independent Non-Executive Director, effective from June 1, 2025. Shattock, known for his extensive leadership experience in consumer goods and retail, is set to bring a wealth of innovation and operational expertise to the company’s board.
Currently serving as the Lead Independent (LON:IOG) Director at The Clorox Company (NYSE:CLX) and a non-executive director at VF Corporation (NYSE:VFC), Shattock’s previous roles include Chairman of Domino’s Pizza (NYSE:DPZ) Group plc and President and CEO of Beam Suntory Inc. During his tenure at Beam Suntory, from 2009 to 2020, he oversaw the integration of Beam and Suntory spirits businesses, achieving a significant transformation of their brand portfolio and accelerating global growth.
Sir Dave Lewis (JO:LEWJ), Chair of Haleon, expressed his enthusiasm for Shattock’s upcoming contribution to the company, highlighting his successful track record in brand building, operational excellence, and value creation. Lewis also noted Shattock’s substantial knowledge of the North American market as a valuable addition to Haleon’s Board.
Haleon is recognized for its commitment to delivering better everyday health through its diverse product portfolio, which includes well-known brands like Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. These brands are founded on trusted science and innovation, coupled with a deep understanding of consumer needs.
The company has confirmed that there are no additional details requiring disclosure under the UK Listing Rules 6.4.6R and 6.4.8R concerning Shattock’s appointment.
This board change comes as Haleon continues to position itself as a leading entity in the consumer health sector. The addition of Shattock’s expertise is expected to further strengthen the company’s strategic direction and governance.
The information in this article is based on a press release statement from Haleon PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.